Compensation award — excluded from discretionary-purchase analysis.
Traded May 8, 2026 · Filed May 12, 2026
Kenvue's General Counsel sold $680K of Kenvue shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$679,691
Shares × reported transaction price
1 day after results of May 7, 2026, 90 days before results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $17.59 on May 8, 2026, 25% above its 52-week low and 28% below its high, little changed over the previous 30 trading days
52-week range $14.11 (Oct 16, 2025) to $24.44 (May 9, 2025), 34% of the way up, from 251 adjusted closes. 30 trading days earlier: $17.57 on Mar 26, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Oct 9, 2023 in the U.S. District Court, D. New Jersey. A filing is an allegation, not a finding.
2 such cases were open. HAMMOND v. KENVUE INC., docket 3:23-cv-20998, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.8% | -0.1% | +0.9% |
| 30 days | +5.5% | -0.1% | +5.6% |
| 90 days | +10.8% | +3.8% | +7.0% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.